The study was not meant to assess whether the spending on drugs and services is cost-effective, although the findings do merit that discussion. (Photo: Rido/Shutterstock.com)

New research indicates that care for the 15 most prevalent types of cancer in the United States cost approximately $156.2 billion in 2018. Medication was the top expense, with drugs for breast, lung, lymphoma and colorectal cancers incurring the most costs.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.